September 09, 2024
Oncology & Hematology
September 09, 2024
Addition of Pembrolizumab to Chemotherapy in EGFR TKI-Resistant, EGFR-Mutant, Metastatic Nonsquamous NSCLC
The ASCO Post
September 09, 2024
Too Much, Too Little, Just Right: Optimizing Cancer Care for Older Adults
The ASCO Post
September 06, 2024
FDA Approves Ready-to-Use Version of Bortezomib for Subcutaneous Administration
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Advertisement
Recommendations
Advertisement